JP2021500399A - 美容レーザーで処置された皮膚の回復を増進する方法 - Google Patents

美容レーザーで処置された皮膚の回復を増進する方法 Download PDF

Info

Publication number
JP2021500399A
JP2021500399A JP2020542533A JP2020542533A JP2021500399A JP 2021500399 A JP2021500399 A JP 2021500399A JP 2020542533 A JP2020542533 A JP 2020542533A JP 2020542533 A JP2020542533 A JP 2020542533A JP 2021500399 A JP2021500399 A JP 2021500399A
Authority
JP
Japan
Prior art keywords
skin
sirna
shrna
laser
fidgetin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020542533A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021500399A5 (enExample
Inventor
オルーク、ブライアン
Original Assignee
マイクロキュアーズ， インコーポレイテッド
マイクロキュアーズ， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マイクロキュアーズ， インコーポレイテッド, マイクロキュアーズ， インコーポレイテッド filed Critical マイクロキュアーズ， インコーポレイテッド
Publication of JP2021500399A publication Critical patent/JP2021500399A/ja
Publication of JP2021500399A5 publication Critical patent/JP2021500399A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/203—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser applying laser energy to the outside of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/067—Radiation therapy using light using laser light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452—Skin
    • A61B2018/00458—Deeper parts of the skin, e.g. treatment of vascular disorders or port wine stains
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452—Skin
    • A61B2018/0047—Upper parts of the skin, e.g. skin peeling or treatment of wrinkles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0616—Skin treatment other than tanning
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/122—Hairpin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/322—2'-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C12N2310/531—Stem-loop; Hairpin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/31—Combination therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/32—Special delivery means, e.g. tissue-specific

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Surgery (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Birds (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Electromagnetism (AREA)
  • Otolaryngology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
JP2020542533A 2017-10-23 2018-10-16 美容レーザーで処置された皮膚の回復を増進する方法 Pending JP2021500399A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762575600P 2017-10-23 2017-10-23
US62/575,600 2017-10-23
PCT/US2018/056007 WO2019083771A1 (en) 2017-10-23 2018-10-16 METHOD FOR IMPROVING THE RECOVERY OF A SKIN TREATED WITH A COSMETIC LASER

Publications (2)

Publication Number Publication Date
JP2021500399A true JP2021500399A (ja) 2021-01-07
JP2021500399A5 JP2021500399A5 (enExample) 2021-11-25

Family

ID=66246670

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020542533A Pending JP2021500399A (ja) 2017-10-23 2018-10-16 美容レーザーで処置された皮膚の回復を増進する方法

Country Status (6)

Country Link
US (2) US20200338111A1 (enExample)
EP (1) EP3700539A4 (enExample)
JP (1) JP2021500399A (enExample)
AU (1) AU2018354054A1 (enExample)
CA (1) CA3079824A1 (enExample)
WO (1) WO2019083771A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8853181B2 (en) 2011-07-21 2014-10-07 Albert Einstein College Of Medicine Of Yeshiva University Fidgetin-like 2 as a target to enhance wound healing
JP2022512785A (ja) * 2018-10-23 2022-02-07 アルバート アインシュタイン カレッジ オブ メディシン 創傷治癒のためのｆｉｄｇｅｔｉｎ様２ ｓｉＲＮＡ強化ポロキサマーベースのヒドロゲル
EP4110318A4 (en) * 2020-02-27 2023-10-11 Microcures, Inc. FIDGETIN-LIKE 2 AS A TARGET MOLECULE TO IMPROVE HEALING OF SKIN TRANSPLANTS
EP4110365A4 (en) * 2020-02-28 2024-03-13 Microcures, Inc. FIDGETIN-LIKE 2 AS A TARGET TO IMPROVE HEALING

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006503681A (ja) * 2002-10-22 2006-02-02 リライアント・テクノロジーズ・インコーポレイテッド 光エネルギーのパターンを用いて皮膚を治療する方法と装置
JP2006520614A (ja) * 2003-03-27 2006-09-14 ザ・ジェネラル・ホスピタル・コーポレイション 皮膚科的処置及び部分的な皮膚の表面再形成のための方法及び装置
JP2009506981A (ja) * 2005-06-09 2009-02-19 チャン，チュアン−チ 創傷治癒用の組成物及びその使用
JP2011507845A (ja) * 2007-12-21 2011-03-10 ガルデマ ラボラトリーズ インコーポレイテッド 手術前治療
US20130022667A1 (en) * 2011-07-21 2013-01-24 Sharp David J Fidgetin-like 2 as a target to enhance wound healing
JP2013511568A (ja) * 2009-11-24 2013-04-04 ビルケン アーゲー 創傷を治癒するためのトリテルペン含有オレオゲルの使用
WO2017135290A1 (ja) * 2016-02-03 2017-08-10 コスメディ製薬株式会社 マイクロニードル用塗布液、マイクロニードル塗布物、及びマイクロニードルアレイ
JP2017189486A (ja) * 2016-04-15 2017-10-19 富士フイルム株式会社 マイクロニードルアレイ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0212652D0 (en) * 2002-05-31 2002-07-10 Univ Bristol Screening Assay
EP1653876A1 (en) * 2003-07-11 2006-05-10 Reliant Technologies, Inc. Method and apparatus for fractional photo therapy of skin
US9114238B2 (en) * 2007-04-16 2015-08-25 Corium International, Inc. Solvent-cast microprotrusion arrays containing active ingredient

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006503681A (ja) * 2002-10-22 2006-02-02 リライアント・テクノロジーズ・インコーポレイテッド 光エネルギーのパターンを用いて皮膚を治療する方法と装置
JP2006520614A (ja) * 2003-03-27 2006-09-14 ザ・ジェネラル・ホスピタル・コーポレイション 皮膚科的処置及び部分的な皮膚の表面再形成のための方法及び装置
JP2009506981A (ja) * 2005-06-09 2009-02-19 チャン，チュアン−チ 創傷治癒用の組成物及びその使用
JP2011507845A (ja) * 2007-12-21 2011-03-10 ガルデマ ラボラトリーズ インコーポレイテッド 手術前治療
JP2013511568A (ja) * 2009-11-24 2013-04-04 ビルケン アーゲー 創傷を治癒するためのトリテルペン含有オレオゲルの使用
US20130022667A1 (en) * 2011-07-21 2013-01-24 Sharp David J Fidgetin-like 2 as a target to enhance wound healing
WO2017135290A1 (ja) * 2016-02-03 2017-08-10 コスメディ製薬株式会社 マイクロニードル用塗布液、マイクロニードル塗布物、及びマイクロニードルアレイ
JP2017189486A (ja) * 2016-04-15 2017-10-19 富士フイルム株式会社 マイクロニードルアレイ

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. Vol.135, No.9, pp.2309-2318, JPN6022047363, 2015, ISSN: 0005098673 *

Also Published As

Publication number Publication date
AU2018354054A1 (en) 2020-06-11
US20230263820A1 (en) 2023-08-24
EP3700539A1 (en) 2020-09-02
US20200338111A1 (en) 2020-10-29
CA3079824A1 (en) 2019-05-02
WO2019083771A1 (en) 2019-05-02
EP3700539A4 (en) 2021-07-14

Similar Documents

Publication Publication Date Title
US20230263820A1 (en) Method for enhancing recovery of cosmetic laser-treated skin
Piccolo et al. Unconventional use of intense pulsed light
Madu et al. Follicular and scarring disorders in skin of color: presentation and management
Liatsopoulou et al. Iontophoresis in dermal delivery: a review of applications in dermato‐cosmetic and aesthetic sciences
Ding et al. Application of integrated skincare in medical aesthetics: A literature review
JP2021500399A5 (enExample)
Hema et al. A review on recent advances and challenges of microneedle technology for enhanced topical treatment of skin disorders
Kamra et al. Liposomes in dermatological diseases
Shehnaz Chemical peels for post acne hyperpigmentation in skin of color
JP2021504391A (ja) 毛包および発毛を修復する方法
KR20220024874A (ko) 트리클로로아세테이트 염 및 히드록시산을 함유하는 치과 및 피부과용 제제
Kwon et al. Effect of cosmetic ingredients as functional agents: synergistic action of electroporation and sonophoresis in clinical efficacy
RU2826643C2 (ru) Композиции для одонтологического и дерматологического применения, содержащие трихлорацетатные соли и гидроксикислоты
EP4157310B1 (en) Therapeutic and cosmetic topical uses of bleomycin
Pourang et al. Microneedling in Clinical Practice: Cosmetic applications
García-Morales et al. Treatment of intralesional corticoisteroid-induced cutaneous atrophy with hyaluronic acid filling
CN119997929A (zh) 用于皮肤的组合物和方法
WO2025096817A1 (en) Compositions and methods for treating skin
KR20250130457A (ko) 피부재생 화장재 조성물 및 이를 포함하는 피부재생 화장재
Kalil et al. Intense Pulsed Light and Drug Delivery
HK40067876A (en) Formulations for odontological and dermatological use containing trichloroacetate salts and hydroxyacids
CN120983292A (zh) 一种黄金三角支撑抗衰方法
TW202214221A (zh) 齒科學及皮膚學使用之含有三氯乙酸鹽及羥酸之配方
Kilmer Omar A. Ibrahimi, Richard E. Fitzpatrick, Mitchel P. Goldman, and Suzanne L. Kilmer
WOO Thursday April 10/Jeudi 10 Avril

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211015

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20211015

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221108

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230207

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230406

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230704